BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16991229)

  • 1. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
    Nikkels AF; Piérard GE
    J Drugs Dermatol; 2006 Sep; 5(8):705-6. PubMed ID: 16991229
    [No Abstract]   [Full Text] [Related]  

  • 2. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.
    Kazinski K; Joyce KM; Hodson D
    J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept.
    Silpa-archa N; Wongpraparut C
    J Med Assoc Thai; 2011 Sep; 94(9):1154-7. PubMed ID: 21970208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
    Conley J; Nanton J; Dhawan S; Pearce DJ; Feldman SR
    J Dermatolog Treat; 2006; 17(2):86-9. PubMed ID: 16766332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
    Gisondi P; Del Giglio M; Cotena C; Girolomoni G
    Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin.
    Antoniou C; Nicolaidou E; Moustou AE; Stratigos A; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):854-5. PubMed ID: 19646137
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau.
    Adişen E; Oztaş M; Gürer MA
    Int J Dermatol; 2007 Nov; 46(11):1205-7. PubMed ID: 17988345
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination therapy with acitretin for psoriasis.
    Hodulik SG; Zeichner JA
    J Dermatolog Treat; 2006; 17(2):108-11. PubMed ID: 16766335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept responsive acrodermatitis continua of Hallopeau: is a pattern developing?
    Bonish B; Rashid RM; Swan J
    J Drugs Dermatol; 2006 Oct; 5(9):903-4. PubMed ID: 17039659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.
    Lutz V; Lipsker D
    Arch Dermatol; 2012 Mar; 148(3):297-9. PubMed ID: 22431771
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau.
    Weisshaar E; Diepgen TL
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):489-92. PubMed ID: 17537042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin.
    Tobin AM; Kirby B
    Br J Dermatol; 2005 Aug; 153(2):445-6. PubMed ID: 16086767
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade).
    Thielen AM; Barde C; Marazza G; Saurat JH
    Dermatology; 2008; 217(2):137-9. PubMed ID: 18503258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.
    Saunier J; Debarbieux S; Jullien D; Garnier L; Dalle S; Thomas L
    Dermatology; 2015; 230(2):97-100. PubMed ID: 25471551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acrodermatitis continua of Hallopeau in a patient with myelodysplastic syndrome.
    van der Kerkhof PC; Steijlen PM; Raymakers RA
    Br J Dermatol; 1996 Apr; 134(4):754-7. PubMed ID: 8733386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
    Puig L; Barco D; Vilarrasa E; Alomar A
    Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial.
    Caproni M; Antiga E; Melani L; Volpi W; Del Bianco E; Fabbri P
    J Clin Immunol; 2009 Mar; 29(2):210-4. PubMed ID: 18763027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis.
    Safa G; Loppin M; Bousser AM; Barbarot S
    J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S19-20. PubMed ID: 17097376
    [No Abstract]   [Full Text] [Related]  

  • 19. Acitretin is a safe treatment option for infantile pustular psoriasis.
    Ergin S; Ersoy-Evans S; Sahin S; Ozkaya O
    J Dermatolog Treat; 2008; 19(6):341-3. PubMed ID: 18608713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acitretin monotherapy in acrodermatitis continua Hallopeau.
    van Dooren-Greebe RJ; van de Kerkhof PC; Chang A; Happle R
    Acta Derm Venereol; 1989; 69(4):344-6. PubMed ID: 2568060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.